23andMe security incident

California’s 2026 settlement announcement adds a scoped affected count and a proposed state agreement to the 2023 credential-stuffing account.

Last modified

Summary

  • Environment: Genetic testing/Biotech
  • Operational impact: California DOJ reports nearly seven million affected US customers
  • Financial impact: California announced a US$6 million agreement, pending approval at announcement
  • Record status: Developing record. Reviewed November 9, 2026; updated as evidence emerges.

What happened

In 2023, 23andMe experienced an incident in its genetic testing/biotech environment. The retained source describes the attack path as follows: Credential stuffing (reused passwords, no forced MFA) plus “DNA Relatives” feature scraping. [2]

Impact

California DOJ’s October 19, 2026 notice describes nearly seven million affected US customers, including more than 855,000 Californians. [1]

California announced a US$6 million settlement with Chrome Holding Co., formerly 23andMe. It was filed in bankruptcy court and pending approval at announcement; a later approval order has not been verified here. This is a state agreement, not a confirmed individual payout. [1]

Timeline

  1. California settlement announced

    The state announcement dates approval status to the announcement.

    [1]
  2. Briefing updated

    This briefing was last reviewed and updated on November 9, 2026.

Threat Group & Attack Vector

The retained source describes the attack path as follows: Credential stuffing (reused passwords, no forced MFA) plus “DNA Relatives” feature scraping. The canonical record does not add intrusion steps beyond those supported by the source. [2]

Actors

  • No threat actor group has been identified in the reviewed public evidence.

TTPs

Response

The retained source describes containment action intended to limit further access or disruption. [2]

The original SEC account and the later California announcement address different stages of this incident.

The California agreement covers alleged security failures and the state’s appeal over the bankruptcy sale of genetic information and samples. The Attorney General reiterated consumers’ deletion and sample-destruction rights. [1]